These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3084990)

  • 1. Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.
    Perumal AS; Smith TM; Suckow RF; Cooper TB
    Neuropharmacology; 1986 Feb; 25(2):199-202. PubMed ID: 3084990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
    Gandolfi O; Barbaccia ML; Chuang DM; Costa E
    Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
    Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.
    Suckow RF; Smith TM; Perumal AS; Cooper TB
    Drug Metab Dispos; 1986; 14(6):692-7. PubMed ID: 2877828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of monoamine uptake inhibitors on norepinephrine-stimulated phosphatidylinositol hydrolysis in rat cortex.
    Mosaddeghi M; Moerschbaecher JM; Gonzales RA
    Biochem Pharmacol; 1989 Jan; 38(2):257-62. PubMed ID: 2536541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central effects of repeated treatment with bupropion.
    Klimek V; Nowak G; Czyrak A
    Pol J Pharmacol Pharm; 1985; 37(3):243-52. PubMed ID: 3934652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain regional [3H]flunitrazepam binding in rats chronically treated with bupropion or B.W.306U.
    Smith TM; Perumal AS; Suckow RF; Cooper TB
    Brain Res; 1986 Mar; 367(1-2):385-9. PubMed ID: 3084038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.
    Dong J; Blier P
    Psychopharmacology (Berl); 2001 Apr; 155(1):52-7. PubMed ID: 11374336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
    Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
    J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection.
    Cooper TB; Suckow RF; Glassman A
    J Pharm Sci; 1984 Aug; 73(8):1104-7. PubMed ID: 6436464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat.
    Tekle A; al-Khamis KI
    J Pharm Pharmacol; 1990 Nov; 42(11):799-801. PubMed ID: 1982306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):293-7. PubMed ID: 2725706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down regulation of beta-receptors by bupropion and its major metabolite in mouse brain.
    Perumal AS; Smith TM; Suckow RF; Cooper TB
    Neuropharmacology; 1986 Dec; 25(12):1323-6. PubMed ID: 3031529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion in depression. I. Biochemical effects and clinical response.
    Golden RN; Rudorfer MV; Sherer MA; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):139-43. PubMed ID: 3122698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
    Dudley MW
    Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion in depression. II. The role of metabolites in clinical outcome.
    Golden RN; De Vane CL; Laizure SC; Rudorfer MV; Sherer MA; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):145-9. PubMed ID: 3122699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.